Imricor Medical Systems Inc (ASX: IMR) - ETF Exposure

Current share price for IMR : $1.300 0.03 (2.26%)⁺

Imricor Medical Systems, Inc. (IMR) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is a Company that is engaged in design, manufacture and sell MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias.

IMR General Information ⁺

ASX Code	IMR
Website	N/A
Industry/Sector	Health Care Equipment
Market Cap ($M)	466
IMR Share Price	$1.300
Day High	$1.320
Day Low	$1.285
Last Close	$1.330
IMR Share Price Movement	$0.03 ( 2.26% )

Prices as at 16:40, 27 Oct 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to IMR

Imricor Medical Systems Inc (IMR) is held across 3 ETFs spanning strategies that include health care equipment exposure . Its weighting in those funds means performance can have an outsized influence - when IMR moves, funds like ISO, SSO and VAS that hold it can move with it.

For more concentrated exposure, ETFs such as ISO (iShares S&P/ASX Small Ordinaries ETF Index Fund) allocate about 0.2% to IMR , while the average exposure across all 3 ETFs that hold it is around 0.1% .

Top ETF holdings

iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO) ~ 0.2%
State Street SPDR S&P/ASX Small Ordinaries ETF (SSO) ~ 0.2%
Vanguard Australian Shares Index ETF (VAS) ~ 0%

Last updated: ETF data and holdings as at 26 October 2026

Own IMR directly or through an ETF?

How does holding Imricor Medical Systems Inc (IMR) shares directly compare to ETFs that include it?

	IMR Direct	ISO ASX	SSO ASX	VAS ASX
Holdings	1 company	219 holdings	219 holdings	334 holdings
IMR Weight	100%	0.2%	0.2%	0%
Diversification	Single Stock	Broad	Broad	Broad
Annual Cost	Brokerage only	0.55% p.a.	0.5% p.a.	0.07% p.a.
Approx. Yield	-	4.69%	9.94%	3.16%
Star Ratings	-

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not IMR's direct yield. Annual cost uses each ETF's MER.

IMR Exposure on $10,000 investment

How a $10,000 investment in Imricor Medical Systems Inc (IMR) one week ago compares with ETFs that hold it.

Security	Investment type	Current price	7-day price movement	Dollar change	Value today
Imricor Medical Systems Inc (IMR)	Direct share	$1.300	-7.14%	-$714	$9,286
iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO)	Equity - Australia Small/Mid Cap	$4.660	-1.89%	-$189	$9,811
State Street SPDR S&P/ASX Small Ordinaries ETF (SSO)	Equity - Australia Small/Mid Cap	$13.500	-1.39%	-$139	$9,861
Vanguard Australian Shares Index ETF (VAS)	Equity - Australia	$109.260	-0.01%	-$1	$9,999

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Imricor Medical Systems Inc (IMR) ETFs

3 ETFs hold Imricor Medical Systems Inc (IMR).

ETF	IMR Weight	MER	Yield
iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO)	0.2%	0.55%	4.69%
State Street SPDR S&P/ASX Small Ordinaries ETF (SSO)	0.2%	0.5%	9.94%
Vanguard Australian Shares Index ETF (VAS)	0%	0.07%	3.16%

Imricor Medical Systems Inc (IMR) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield

See all dividends from Imricor Medical Systems Inc (IMR) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Imricor Medical Systems Inc (IMR) price-sensitive announcements

IMR - FDA Completes Review of Third PMA Module

Imricor Medical Systems announced that the U.S. Food and Drug Administration has completed

Imricor Medical Systems Inc (IMR)
8 Oct 2026 | 9:17 AM

IMR - S&P DJI Announces September 2026 Quarterly Rebalance

S&P Dow Jones Indices announced on 4 September 2026 the September 2026 quarterly rebalance

Imricor Medical Systems Inc (IMR)
4 Sep 2026 | 5:10 PM

IMR - FDA Accepts Imricor PMA Manufacturing Module

Imricor Medical Systems announced that the U.S. Food and Drug Administration has completed

Imricor Medical Systems Inc (IMR)
3 Sep 2026 | 8:21 AM

IMR - Imricor and Philips Launch Commercial iMR Lab Solution

Imricor Medical Systems, Inc. announced the commercial launch of a combined interventional

Imricor Medical Systems Inc (IMR)
28 Aug 2026 | 8:16 AM

Imricor Medical Systems Inc (IMR) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Imricor Medical Systems Inc (IMR) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB	Health Care	$466	Notification of cessation of securities - IMR	13 Oct 2026 10:38AM	$1.445	$1.300	fallen by 10.03%
Imricor Medical Systems Inc (IMR) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB	Health Care	$466	Notification regarding unquoted securities - IMR	12 Oct 2026 9:24AM	$1.385	$1.300	fallen by 6.14%
Imricor Medical Systems Inc (IMR) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB	Health Care	$466	FDA Completes Review of Third PMA Module	8 Oct 2026 9:17AM	$1.450	$1.300	fallen by 10.34%
Imricor Medical Systems Inc (IMR) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB	Health Care	$466	Cleansing Notice	18 Sep 2026 9:35AM	$1.795	$1.300	fallen by 27.58%
Imricor Medical Systems Inc (IMR) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB	Health Care	$466	Application for quotation of securities - IMR	18 Sep 2026 9:34AM	$1.795	$1.300	fallen by 27.58%
Imricor Medical Systems Inc (IMR) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB	Health Care	$466	S&P DJI Announces September 2026 Quarterly Rebalance	4 Sep 2026 5:10PM	$1.960	$1.300	fallen by 33.67%

IMR Financial Summary

Year to Dec	NPAT	EPS	EPS chg (%)	Yield (%)	Franking (%)
2025A	-$37.83	-$12.30	-42.50%	0.00%	0.0%
2024A	-$47.76	-$21.30	1.00%	0.00%	0.0%
2023A	-$33.08	-$21.10	20.10%	0.00%	0.0%

IMR Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2023 A	2024 A	2025 A	2023 A	2024 A	2025 A	2023 A	2024 A	2025 A
Cochlear Limited (COH)	$9,601M	-0.3136	0.2540	0.0785	35.7419	28.5024	26.4280	2.35%	2.44%	2.66%
Fisher & Paykel Healthcare Corporation Limited (FPH)	$23,342M	0.1388	0.1444	0.1574	60.0030	52.4313	45.3020	1.09%	1.18%	1.31%
Imricor Medical Systems Inc (IMR)	$466M	-0.4254	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
ResMed Inc. (RMD)	$20,473M	9.5922	0.0986	0.0915	23.3167	21.2234	19.4444	1.00%	1.08%	1.17%

IMR Directors

Name	Position	Start Date
Mr Steve Wedan	Chief Executive Officer, President, Executive Chairman, Executive Director	23 May 2006
Mr Mark Tibbles	Non-Executive Deputy Chairman, Non-Executive Director	3 Sep 2014
Mr Peter McGregor	Non-Executive Director	17 May 2019
Ms Anita Messal	Non-Executive Director	1 Mar 2021
Mr Jeffrey Leighton	Non-Executive Director	31 Jul 2024
Mr Aldo Denti	Non-Executive Director	6 Nov 2025

Imricor Medical Systems Inc (IMR) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
5 Jun 2025	TIBBLES, Mark	Transfer	Direct Shares	73,380	$1.090	$80,000.000
5 Jun 2025	TIBBLES, Mark	Sell	Direct Shares	170,000	$1.684	$286,360.000
22 May 2024	WEDAN, Steve	Buy	Indirect Shares	100,000	$0.450	$45,000.000

See all changes in directors' interest & trades for Imricor Medical Systems Inc (IMR) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

IMR Management

Name	Position
Zheng(Kobe) Li	Company Secretary
Kate Lindborg	Vice President of Clinical Affairs
Nick Corkill	Vice President of Corporate Strategy
Jonathon Gut	Vice President of Finance and Chief Financial Officer
Greg Englehardt	Vice President of Global Sales
Nick Twohy	Vice President of Marketing and Business Development
Vic Fabano	Vice President of Operations
Jennifer Weisz	Vice President of Regulatory and Quality
Gregg Stenzel	Vice President of Research and Development

IMR Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Imricor Medical Systems Inc (IMR). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
19,378,198 (6.04%)	Hart Capital Partners
18,462,138 (5.75%)	Greencape Capital Pty Ltd

IMR Calendar of Events

Date	Event
26 March 2027	Report (Annual)
24 February 2027	Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us